Product Information
LUBIPROSTONE 24 MCG CAPSULE is a generic product labeled by Camber Pharmaceuticals Inc., priced at $0.6460 per EA under NDC 31722040460. Its NADAC has been published 40 times since Sep 24, 2025.
Strength
.024 mg/1
Manufacturer
Camber Pharmaceuticals Inc.NDC
31722040460
Classification
Generic
Dosage Form
CAPSULE
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
LUBIPROSTONEApproval Type
Generic (ANDA)
FDA Application
ANDA218640On Market Since
5/27/2025
Pharmacological Classes
Price Statistics
The NADAC for LUBIPROSTONE 24 MCG CAPSULE has been published 40 times since Sep 24, 2025, and over the history we have for it it has declined 21.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.6460 per EA |
|---|---|
| All-time high | $0.8250 (Oct 15, 2025) |
| All-time low | $0.6460 (Jun 17, 2026) |
| 52-week high | $0.8250 |
| 52-week low | $0.6460 |
| Median price | $0.7861 |
| Average price | $0.7490 |
| Largest weekly change | -5.9% (Mar 18, 2026) |
| Weeks tracked | 40 |
| Tracking since | Sep 24, 2025 |
Generic Alternatives
The matcher finds 1 NADAC-published product sharing this drug's active ingredient, strength, and dosage form across 1 manufacturer (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of LUBIPROSTONE 24 MCG CAPSULE?
The current National Average Drug Acquisition Cost (NADAC) for LUBIPROSTONE 24 MCG CAPSULE, manufactured by Camber Pharmaceuticals Inc., is $0.6460 per EA (NDC 31722040460), effective Jun 24, 2026.
How has the price of LUBIPROSTONE 24 MCG CAPSULE changed over time?
Over the history we have for it, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has declined 21.7%. It has been tracked across 40 weekly CMS publications since Sep 24, 2025.
What are the highest and lowest recorded NADAC prices for LUBIPROSTONE 24 MCG CAPSULE?
Since Sep 24, 2025, the NADAC for LUBIPROSTONE 24 MCG CAPSULE has ranged from a low of $0.6460 (Jun 17, 2026) to a high of $0.8250 (Oct 15, 2025), with a median of $0.7861 per EA.
Are there cheaper alternatives to LUBIPROSTONE 24 MCG CAPSULE?
1 NADAC-published product shares the same active ingredient, strength, and dosage form as LUBIPROSTONE 24 MCG CAPSULE, but none are currently priced below it.
Who manufactures LUBIPROSTONE 24 MCG CAPSULE?
LUBIPROSTONE 24 MCG CAPSULE (NDC 31722040460) is labeled by Camber Pharmaceuticals Inc., and CMS classifies it as a generic product.
Related Drugs
Same classification